| Literature DB >> 20934769 |
Sang Youl Rhee1, Young Seol Kim, Suk Chon, Seungjoon Oh, Jeong-Taek Woo, Sung Woon Kim, Jin-Woo Kim.
Abstract
We analyzed the medical records of 884 type 2 DM patients who were taking different antiplatelet agents for more than 2 years. Based on the records, occurrences of cardiovascular events for 10 years were evaluated. The composite disease-free survival rate for cilostazol monotherapy group was similar to aspirin subgroup (p=0.133). 2010 Elsevier Ireland Ltd. All rights reserved.Entities:
Mesh：
Substances：
Year: 2010 PMID： 20934769 DOI： 10.1016/j.diabres.2010.09.009
Source DB: PubMed Journal: Diabetes Res Clin Pract ISSN： 0168-8227 Impact factor: 5.602